TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mean probing pocket depths (PPD) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of gingival recession (GR)
Endpoint domain: Adverse events/effects
Primary endpoint: Time spent in triadic engagement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of superficial sternal wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of sternal instability
Endpoint domain: Adverse events/effects
Primary endpoint: Body Fat Percentage (BF%) prediction accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: odor discrimination and identification abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and severity of suicidal behaviors and ideations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily consumption of fruit and vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Program retention through L&D
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: College persistence following L&D
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Discriminability of the algorithm in detecting PGES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual-level abortion stigma score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of Life parameters
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of follow-up care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Target Lesion Failure (TLF) rate
Endpoint domain: Mortality/survival
Primary endpoint: Definite scaffold thrombosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Expanded Prostate Cancer Index Composite‐sexual function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of residual clinically significant prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall success rates for treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mouth aperture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy for identifying SLE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for early disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for severe lupus requiring immunosuppressives/biologics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-satisfaction with appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall treatment satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hemi-MASI score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement of pigmented lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement of vascular component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: time to spare after crossing the road
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: full-mouth plaque reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: marked symptomatic relief
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total prevalence rate of adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Compliance of patients with PICC
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Longest time of indwelling catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUD rates among people with SMI
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive impairment (MMSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional impairment (Barthel Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Care related needs
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: overall success rate based on assessment of symptom relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Visual Analog Scale (VAS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative additional analgesic requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative blood glutathione peroxidase values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health-related outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Job-burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gustatory dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of large artery stroke (LAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of retinal eye exams obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥3 CAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in DRS from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: life-threatening or fatal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Signal intensity of the graft on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in the quality of intestinal preparation for colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: insomnia symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: REM segment duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour mean ambulatory systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: office systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: medication burden
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Stacy score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of vagal effects
Endpoint domain: Adverse events/effects
Primary endpoint: Time of bowel sound recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to the first postoperative exhaust and defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time of postoperative liquid diet recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Passive VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Avoidance of acute admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Progression to a poorer frailty category
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: noncardiac mortality
Endpoint domain: Mortality/survival
Primary endpoint: Joint pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Flexion increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Joint condition improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: predicted FVC%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post-operative ocular hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Development of complications
Endpoint domain: Adverse events/effects
Primary endpoint: sedentary time expressed as daily minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sedentary time as proportion of wake/wear time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alpha power density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased plasma creatinine and urea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increased activities of ADA and xanthine oxidase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decreased plasma albumin and renal glutathione
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Median time for onset of mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time for remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Grade IV mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Serum Uric Acid (SUA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sXOA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: goal intentions
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: self-efficacy beliefs
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Ratio of AEMG (convex/concave)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of IEMG (convex/concave)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HBL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of erythrocyte transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PD15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with negative PD15 test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in airway tissue eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in BAL eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Thigh pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reported confidence in solutions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: experimenter‐rated effectiveness of solutions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intention to implement solutions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Single-leg stance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Developmental Quotient (DQ) of gross motor, fine motor, and personal-social interaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QALY change for PwMCI
Endpoint domain: Resource use
Primary endpoint: QALY change for informal caregivers
Endpoint domain: Resource use
Primary endpoint: QALY change for PwMCI and informal caregivers combined
Endpoint domain: Resource use
Primary endpoint: Bench press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squat strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average TTR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of ischaemic stroke events
Endpoint domain: Mortality/survival
Primary endpoint: ITT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of reliably recovered patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Higher scores on the MC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of a crossbite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of a high-arched palate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive ADA assay responses
Endpoint domain: Adverse events/effects
Primary endpoint: Injury incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Medial tibial stress syndrome incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Explanatory knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ability to apply learning to solve novel clinical problems
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean hazard ratio
Endpoint domain: Mortality/survival
Primary endpoint: mean log-rank p value
Endpoint domain: Mortality/survival
Primary endpoint: improved pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical ergonomics improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand-eye coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Enrollment in the course
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Commencement of the program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Course completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: symptomatic with parasitaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: treatment related gastrointestinal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Biochemical failure-free survival (BFFS)
Endpoint domain: Mortality/survival
Primary endpoint: Distant metastasis-free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: risk of kidney failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: death from cardiovascular causes or hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Changes in subjective UI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNAm changes at chronological-age associated CpG sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean scores of premenstrual syndrome symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort level of RSL stimuli
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment response in chronic migraine patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of LMA insertion on the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in LEKS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mucosal edema formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypothetical consent rate for routine data and left-over samples
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: active straight leg raise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of apoptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of drug‐associated side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence rate of IUA
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of timely and complete discharge summaries
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VM and VL muscle activity during step tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean change in fasting glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TPB score change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Skill score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: SNM device implantation within three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: consumption of analgesic drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of Surgical Site Infection (SSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Brain stem reflexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: RGV values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower incidence rate of non-contact lower-extremity injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvements in dermatologic endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Visual analog scale (VAS) scores on coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: Macular closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Imatinib concentration at 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life of imatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder volume on tUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average increases in APD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Traumatic Stress Disorder (PTSD) symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complex PTSD (CPTSD) symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Major Depressive Disorder (MDD) symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proinflammatory cytokine response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: resting Tmn
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: circulating adenosine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from Severe Acute Malnutrition (SAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-for-height Z-score (WHZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and diagnostic accuracy for pancreatic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Necrotizing enterocolitis (NEC)
Endpoint domain: Adverse events/effects
Primary endpoint: Early postprandial uptake of branched chain amino acids (BCAA) into skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak glycaemic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial whole body fat oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean FLACC behavioral pain assessment scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean Wong-Baker FACES pain rating scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in child growth trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to alleviation of signs and symptoms of influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean NRS (Numeric Rating Scale) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral health-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: oral health-related attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: oral health-related behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall symptom score on a visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain at the injection site
Endpoint domain: Adverse events/effects
Primary endpoint: Patient involvement in therapeutic decision making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean score of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean episodes number of nighttime frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes